Jaguar Health, Inc. Reports 2020 Third Quarter Financial Results
Third quarter 2020 Mytesi net sales and gross sales were approximately $2.8 million and approximately $6.3 million, respectively Company to...
Staff
Halberd Corp. CEO Interviewed on Money TV; Discusses New Fluorescent Covid-19 Antibody
Mr. Hartman discusses advantages over existing antibodies JACKSON CENTER, PA / ACCESSWIRE / November 16, 2020 / Halberd Corporation (OTC PINK:HALB)...
9 Meters Biopharma Announces Positive Preclinical Data for NM-102, a Gut Microbiome Modulator in an Immune Checkpoint Inhibitor Failure Model
NM-102, a novel next-generation microbiome modulator, shows positive effect in an aggressive immune checkpoint inhibitor failure melanoma model IND-enabling planning...
Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020
MORRISVILLE, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a...
TRHC Forms a Strategic Alliance with the American College of Apothecaries (ACA) to Market TRHC Solutions to Members
MOORESTOWN, N.J., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (Nasdaq: TRHC), a healthcare technology company advancing the field of...
XORTX Announces Topline Results from Mount Sinai’s COVID-19 Clinical Study
● Early & High Uric Acid dose dependent association in Acute Kidney Injury from COVID-19 ● CALGARY, Alberta, Nov. 16,...
Innovation Pharmaceuticals Announces Overseas Regulatory Filing Submitted For COVID-19 Clinical Study
New in vitro data also demonstrates Brilacidin’s anti-SARS-CoV-2 potency is unlikely to be impacted by mutations in different strains of...
Artelo Biosciences Announces Clinical Trial Authorization to Commence Cancer Appetite Recovery Study for the Treatment of Cancer-Related Anorexia and Weight Loss
First patients on track for enrollment this year Targeting multi-billion market with no approved therapies for cancer-related anorexia LA JOLLA,...
Vaxart Hosting Key Opinion Leader Panel Call for Investors
Title: An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus Key topics:COVID-19: Immunity & Immunological MemoryNorovirus:...
PDS Biotech Announces New and Broad Versamune® Platform Patent Claims
Granted methods patent for Versamune® platform by the United States Patent and Trademark Office FLORHAM PARK, N.J., Nov. 16, 2020...
Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin
- Company to receive upfront payment of €5 million replacing a later stage regulatory approval milestone of U.S.$5 million -...
Cocrystal Pharma Reports Third Quarter 2020 Financial Results and Provides Update on Antiviral Programs
– Continued progress of COVID-19 development programs with additional preclinical studies of coronavirus protease inhibitors (3CL) underway and lead preclinical...
Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and management
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum...
Ziopharm Oncology Appoints Mary Thistle to Board of Directors
– Special Advisor and Former Chief of Staff for the Bill & Melinda Gates Medical Research Institute Joins as Independent...
Alimera Sciences Announces Participation at the 11th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020
ATLANTA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development...
Philips continues its top ranking in the Dow Jones Sustainability Indices
CLC South-Africa Bouwdokken Refurbishment Process MRI November 16, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a...
CRISPR Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Quanta to Participate in Upcoming Virtual Investor Conferences
ALCESTER, United Kingdom, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical...
Receptor Life Sciences Receives Schedule I Research License from U.S. Drug Enforcement Agency
SEATTLE, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences announced today that the Company was granted a Schedule I...
Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB) and Door Pharmaceuticals, LLC today announced...